Chemical Engineering @ChemengFiles.Com

Cellectricon has announced its collaboration with the University of Lodz (Poland). Under the agreement, the University of Lodz will invest in Cellaxess (R) HT, the world's first system for high transfection efficiency that allow delivery of reagents free of any genetic material to cells.

"We are excited in relation to collaboration with Cellectricon, and we believe that the system Cellaxess (R) HT will be a big step forward for our efforts within our research program focused on cell biology and molecular genetics of genes associated with clinically relevant treatment cancer, "said Bartosz profesorGrzegorz, head of the department of molecular biophysics at the University of Lodz. The genomic control is a rapidly evolving field, and the need is very important around the technology that allows a high transfection efficiency and viability in most cell types. Cellaxess (R) HT will allow us to take an ambitious expression and mute control processes that would otherwise have been viable in the economic aspect in the study with conventional instrumentation. The acquisition system Cellaxess (R) HT by the University of Lodz was made possible by funds from the Operational Program Innovative Economy Republic of Poland, which have been supported in part by the European Union through the Fund European Regional Development.

"Cellectricon has developed the system in collaboration with leading research groups and major pharmaceutical companies to meet increasing demand for a generic technology can have a real high transfection efficiency, indicóJonas Ohlsson, CEO of Cellectricon. "Cellaxess (R) HT considerable impact of this scientific field, as it allows the freedom of high performance reagents supplied in any genetic material for the cell types relevant from a biological point of view."